Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 2Urinary Bladder Neoplasms 1Tuberculosis, Pulmonary 1Solitary Pulmonary Nodule 1Pulmonary Fibrosis 1Pulmonary Embolism 1Pulmonary Disease, Chronic Obstructive 1Pulmonary Arterial Hypertension 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Multiple Pulmonary Nodules 1Lymphoma, Follicular 1Lung Injury 1Lung Diseases, Interstitial 1Lung Diseases 1Lung Abscess 1Emphysema 1Dementia 1Cystic Fibrosis 1Colorectal Neoplasms 1Cognitive Dysfunction 1Bronchitis 1Bronchiectasis 1Breast Neoplasms 1Breast Cancer Female 1Asthma 1Alzheimer Disease 1

Interventions

Tomography, X-Ray Computed 1Mastectomy, Segmental 1Hematologic Tests 1Drug Delivery Systems 1Diagnostic Imaging 1Anti-Bacterial Agents 1Anterior Temporal Lobectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Solitary Pulmonary Nodule × Drug Delivery Systems × Clear all
NCT06518655 2025-12-24

Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath

ChromX Health

Recruiting
3,000 enrolled
Thoracic

Solitary Pulmonary Nodule, Lung Neoplasms, Multiple Pulmonary Nodules

Data powered by HemOnc (CC BY 4.0) Colophon âš¡